The current EVAX market cap is 0. The company's latest EPS is USD and P/E is N/A.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 507k |
Operating Income | -6.53M | -6.39M | -5.68M | -5.76M | -135.06M |
Net Income | -6.87M | -6.24M | -5.68M | -5.68M | -134.81M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 507k |
Operating Income | -10.86M | -16.57M | -25.83M | -25.26M | -152.9M |
Net Income | -11.2M | -15.02M | -24.53M | -23.17M | -152.41M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 22.03M | 20.49M | 16.75M | 11.94M | 86.93M |
Total Liabilities | 13.72M | 13.91M | 14.22M | 14.68M | 118.82M |
Total Equity | 8.3M | 6.58M | 2.54M | -2.73M | -31.89M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.08M | 11.97M | 40.16M | 22.03M | 86.93M |
Total Liabilities | 1.72M | 4.93M | 7.73M | 13.72M | 118.82M |
Total Equity | 9.36M | 7.04M | 32.44M | 8.3M | -31.89M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -25.77M | N/A | N/A | N/A | -124.8M |
Investing | -268k | N/A | N/A | N/A | -651k |
Financing | 7.85M | N/A | N/A | N/A | 72.89M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -7.02M | -12.44M | -21.93M | -25.77M | -124.8M |
Investing | -68k | -393k | -1.33M | -268k | -651k |
Financing | 9.51M | 8.82M | 49.81M | 7.85M | 72.89M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 5.18 (64.75%) |
Company Name | Evaxion Biotech AS |
Address |
dr. neergaards vej 5f horsholm 2970 |
Website | https://www.evaxion-biotech.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.